AR and alcoholic liver diseases: Previous research has shown that the AR, a key enzyme in the polyol pathway, which is a monomeric oxidoreductase that catalyses the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent reduction of a wide variety of carbonyl compounds, can be up-regulated in patients with alcoholic liver diseases.